Boston Scientific issues software correction for 3,592 pacemakers and cardiac devices
The FDA says Boston Scientific has opened a worldwide correction for software used in certain ACCOLADE-family pacemakers and CRT-P devices.
The FDA says Boston Scientific has opened a worldwide correction for software used in certain ACCOLADE-family pacemakers and CRT-P devices.
The FDA listed an early alert on July 24, 2026, involving a Boston Scientific percutaneous catheter and said it was collecting additional information.